Literature DB >> 14505278

Pneumonic plague.

Ganesh Krishna1, Rajinder K Chitkara.   

Abstract

Pneumonic plague, a disease caused by the bacterium Yersinia pestis, is a rare disease in the United States and carries a high mortality. Health care professionals in the United States are not familiar with the clinical presentation and diagnosis of plague pneumonia. The wide prevalence of the bacterium in different parts of the world, its high virulence, and its ability to spread by aerosolization makes it a potential agent of biological warfare in the hands of terrorists. This review focuses on the prevalence, pathogenesis immunity, clinical manifestations, diagnosis, treatment, and prevention of plague pneumonia, with particular emphasis on the plague bacillus as an agent of biological warfare. Based on available information, we discuss measures that need to be undertaken by health care personnel, public health personnel, and epidemiologists in the event of such an attack.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14505278

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  7 in total

1.  Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.

Authors:  Anna N Honko; Nammalwar Sriranganathan; Cynthia J Lees; Steven B Mizel
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

Review 2.  Receptor mimicry as novel therapeutic treatment for biothreat agents.

Authors:  Richard J Thomas
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

3.  Different pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols.

Authors:  Richard J Thomas; Daniel Webber; Aaron Collinge; Anthony J Stagg; Stephen C Bailey; Alejandro Nunez; Amanda Gates; Pramukh N Jayasekera; Rosa R Taylor; Steve Eley; Richard W Titball
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

4.  Levofloxacin cures experimental pneumonic plague in African green monkeys.

Authors:  Robert Colby Layton; William Mega; Jacob D McDonald; Trevor L Brasel; Edward B Barr; Andrew P Gigliotti; Frederick Koster
Journal:  PLoS Negl Trop Dis       Date:  2011-02-08

5.  Induction of Protective Antiplague Immune Responses by Self-Adjuvanting Bionanoparticles Derived from Engineered Yersinia pestis.

Authors:  Xiuran Wang; Amit K Singh; Xiangmin Zhang; Wei Sun
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

6.  Early host cell targets of Yersinia pestis during primary pneumonic plague.

Authors:  Roger D Pechous; Vijay Sivaraman; Paul A Price; Nikolas M Stasulli; William E Goldman
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

7.  Metabolomic analyses reveal lipid abnormalities and hepatic dysfunction in non-human primate model for Yersinia pestis.

Authors:  Aarti Gautam; Seid Muhie; Nabarun Chakraborty; Allison Hoke; Duncan Donohue; Stacy Ann Miller; Rasha Hammamieh; Marti Jett
Journal:  Metabolomics       Date:  2018-12-29       Impact factor: 4.290

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.